Literature DB >> 10084575

Longitudinal hormonal and pituitary imaging changes in two females with combined pituitary hormone deficiency due to deletion of A301,G302 in the PROP1 gene.

B B Mendonca1, M G Osorio, A C Latronico, V Estefan, L S Lo, I J Arnhold.   

Abstract

Genomic DNA from 18 patients with combined pituitary hormone deficiency was screened for 2-bp deletion (A301,G302) in PROP1 gene by BcgI restriction endonuclease analysis of PCR-amplified exon 2 gene fragments. Two unrelated female patients were homozygous for this 2-bp deletion. Patient 1 presented at 8.8 yr with severe short stature (-2.9 SD score), slightly enlarged sella turcica at x-rays, and diffusely enlarged pituitary gland (height, 8 mm vs. 4.5 +/- 0.6 mm in matched controls) with hyperintense enhanced signal at T1 weighted image at coronal and sagittal views at magnetic resonance imaging (MRI). MRI repeated at age 15 yr revealed a marked reduction of pituitary height (2 mm vs. 5.3 +/- 0.8 mm in matched controls). Patient 2 presented at 27 yr with short stature (-5.5 SD score) without pubertal development, normal sella turcica, and a pituitary gland of reduced size (height, 5 mm vs. 6.1 +/- 0.3 mm in matched controls) of normal intensity at MRI. Both patients had normal pituitary stalk and normally located neurohypophysis. Hormonal features were characterized by GH, TSH, PRL, LH, and FSH deficiencies. Patient 1 had normal cortisol secretion at 8.8 yr, and at 16.6 yr had developed partial cortisol deficiency, whereas patient 2 maintained normal cortisol secretion at 28.4 yr. We conclude that 1) a large sella turcica and an enlarged pituitary anterior lobe with hyperintense enhanced signal at T1 at MRI can be suggestive of PROP1 deficiency; 2) pituitary morphology can change during follow-up of patients with PROP1 gene mutation; and 3) hormonal deficiencies could include the adrenal axis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10084575     DOI: 10.1210/jcem.84.3.5537

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  26 in total

Review 1.  Other transcription factors and hypopituitarism.

Authors:  Laurie E Cohen; Sally Radovick
Journal:  Rev Endocr Metab Disord       Date:  2002-12       Impact factor: 6.514

2.  Untreated hypopituitarism due to absence of the pituitary stalk with normal adult height: report of two cases.

Authors:  Leda Papastathopoulou; Marinella Tzanela; Vania Vlassopoulou; Dimitra Vassiliadi; Nikolaos Thalassinos
Journal:  Endocrine       Date:  2006-02       Impact factor: 3.633

3.  Pituitary size fluctuation in long-term MR studies of PROP1 deficient patients: A persistent pathophysiological mechanism?

Authors:  A Voutetakis; A Sertedaki; S Livadas; P Xekouki; I Bossis; C Dacou-Voutetakis; M I Argyropoulou
Journal:  J Endocrinol Invest       Date:  2006-05       Impact factor: 4.256

Review 4.  The role of homeodomain transcription factors in heritable pituitary disease.

Authors:  Kelly L Prince; Emily C Walvoord; Simon J Rhodes
Journal:  Nat Rev Endocrinol       Date:  2011-07-26       Impact factor: 43.330

5.  Case seminar: a young female with acute hyponatremia and a sellar mass.

Authors:  Sandra Pekic; Mirjana Doknic; Dragana Miljic; Alexandru Saveanu; Rachel Reynaud; Anne Barlier; Thierry Brue; Vera Popovic
Journal:  Endocrine       Date:  2011-08-24       Impact factor: 3.633

6.  CTNNB1 gene mutations, pituitary transcription factors, and MicroRNA expression involvement in the pathogenesis of adamantinomatous craniopharyngiomas.

Authors:  Marina Lanciotti Campanini; Leandro Machado Colli; Beatriz Maria Carvalho Paixao; Tatiana Pereira Freitas Cabral; Fernando Colbari Amaral; Helio Rubens Machado; Luciano Serafin Neder; Fabiano Saggioro; Ayrton Custodio Moreira; Sonir Roberto Rauber Antonini; Margaret de Castro
Journal:  Horm Cancer       Date:  2010-08       Impact factor: 3.869

7.  A homozygous mutation in HESX1 is associated with evolving hypopituitarism due to impaired repressor-corepressor interaction.

Authors:  Luciani R Carvalho; Kathryn S Woods; Berenice B Mendonca; Nathalie Marcal; Andrea L Zamparini; Stefano Stifani; Joshua M Brickman; Ivo J P Arnhold; Mehul T Dattani
Journal:  J Clin Invest       Date:  2003-10       Impact factor: 14.808

Review 8.  Magnetic resonance imaging of the hypothalamus-pituitary unit in childrensuspected of hypopituitarism: who, how and when toinvestigate.

Authors:  M Maghnie; S Ghirardello; E Genovese
Journal:  J Endocrinol Invest       Date:  2004-05       Impact factor: 4.256

9.  Genesis of two most prevalent PROP1 gene variants causing combined pituitary hormone deficiency in 21 populations.

Authors:  Petra Dusatkova; Roland Pfäffle; Milton R Brown; Natallia Akulevich; Ivo J P Arnhold; Maria A Kalina; Karolina Kot; Ciril Krzisnik; Manuel C Lemos; Jana Malikova; Ruta Navardauskaite; Barbora Obermannova; Zuzana Pribilincova; Agnes Sallai; Gordana Stipancic; Rasa Verkauskiene; Ondrej Cinek; Werner F Blum; John S Parks; Frederic Austerlitz; Jan Lebl
Journal:  Eur J Hum Genet       Date:  2015-06-10       Impact factor: 4.246

10.  Adrenocorticotrope deficiency with clinical evidence for late onset in combined pituitary hormone deficiency caused by a homozygous 301-302delAG mutation of the PROP1 gene.

Authors:  C Lamesch; S Neumann; R Pfäffle; W Kiess; R Paschke
Journal:  Pituitary       Date:  2002       Impact factor: 4.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.